Editas Medicine, one of the small handful of original CRISPR companies, announced Thursday it is halting development on its first clinical program after data
Tag - biotechnology
Biogen named Christopher Viehbacher, who formerly ran the French drug giant Sanofi, as its new CEO on Thursday, opening a new chapter for one of the first and
Relmada Therapeutics said Thursday that its experimental treatment for depression failed to achieve the primary goals of a large clinical trial, a significant
WASHINGTON — Michelle McMurry-Heath, one of the most prominent faces of the drug industry in Washington, is on leave from her role as CEO of the Biotechnology
The Food and Drug Administration approved a new medicine for ALS from Amylyx Pharmaceuticals on Thursday, providing a desperately-needed new treatment option
SAN DIEGO — After a steep drop in its stock price and with mounting competition from rivals, genomics giant Illumina on Thursday launched a new line of high
Rheumatology — the study of immune-system-driven diseases of the bones, joints, muscles, and in-betweens — has inherited plenty of hand-me-downs from cancer
Detailed data from a successful heart disease study show a therapy developed by Alnylam Pharmaceuticals performed significantly better than placebo, but the
SAN DIEGO — Sequencing behemoth Illumina on Thursday won its case against the Federal Trade Commission in its bid to hold onto Grail, a Bay Area early cancer
After a lengthy review, the Food and Drug Administration approved a fast-acting depression treatment from Axsome Therapeutics on Friday, clearing the way for
